RxDoctor Payments Data

Dustin Blackwell, DO

Obstetrics · Vincennes, INNPI 1841682374

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (35.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Biogen at 46.1% of the total. 2025 is the largest year on record at $10,504, more than ten times the $511 reported in 2019. Among obstetrics clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,852in general payments, 2019–2025

Across 135 payments — averaging $161.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$10K
  • Intuitive Surgical$9K
  • Covidien LP$960
  • Medical Device Business Services, Inc.$325
  • Exeltis, USA Inc.$214
  • Pfizer$169
  • plus $1K from 26 others

What the payments were for

  • Consulting fees$4,36820%
  • Speaking & faculty fees$5,40825%
  • Travel & lodging$1,7608%
  • Food & beverage$2,49111%
  • Education$7,82536%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,852 in reported general payments places this provider in the 95th percentile of 20 obstetrics providers in Indiana.

See all obstetrics providers in Indiana

Medicare billing

Part B allowed, 2024
$26,768
Medicare patients
146
Services billed
282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol32$1,510
ProgesteroneProgesterone, Micronized35$1,208
Medroxyprogesterone Acetate26$539
Megestrol Acetate11$165
Mometasone Furoate15$158

Paid to pharmacies, not to this prescriber.

Other obstetrics in Vincennes

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →